• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳心颗粒对心肌浦肯野纤维的抗心律失常作用及机制研究。

Antiarrhythmic effects and potential mechanism of WenXin KeLi in cardiac Purkinje cells.

机构信息

Department of Cardiology, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Buchang Cardio-cerebrovascular Hospital, Xian, China.

出版信息

Heart Rhythm. 2016 Apr;13(4):973-82. doi: 10.1016/j.hrthm.2015.12.023. Epub 2015 Dec 14.

DOI:10.1016/j.hrthm.2015.12.023
PMID:26699239
Abstract

BACKGROUND

Previous studies have demonstrated that WenXin KeLi (WXKL), a traditional Chinese medicine, can exert antiarrhythmic properties through complex multichannel inhibition, but its pharmacologic effect remains to be elucidated, especially in the cardiac conductive system.

OBJECTIVE

To explore the antiarrhythmic property of WXKL in cardiac Purkinje cells (PCs).

METHODS

PCs were isolated from rabbit hearts and action potentials (APs) and ion currents were recorded by whole-cell patch clamp technique. Anemonia toxin II (ATX-II) and isoproterenol (ISO) were used to induce early or delayed afterdepolarizations (EADs, DADs) or triggered activities (TAs).

RESULTS

WXKL (1 g/L and 5 g/L) significantly abbreviated the action potential duration (APD) of PCs in a dose- and rate-dependent manner. Treatment of PCs with ATX-II (2 nM) prolonged APD and induced EADs, which were significantly suppressed by WXKL. WXKL (1, 5 g/L) also inhibited ISO-induced EADs, DADs, and TAs. To reveal the ionic mechanisms, we studied the effects of WXKL on late sodium current (I(NaL)), peak sodium current (I(NaP)), and L-type calcium currents (ICaL) in PCs. WXKL-attenuated ATX-II (5 nM) induced I(NaL) augmentation and blocked I(NaL) with an IC50 of 4.3 ± 0.5 g/L, which is 3- to 4-fold more selective than that of I(NaP) (13.3 ± 0.9 g/L) and ICaL (17.6 ± 1.4 g/L). Moreover, WXKL exerted significantly less use-dependent block of I(NaP) than that of flecainide, indicating its lower proarrhythmic effect.

CONCLUSIONS

WXKL exhibits antiarrhythmic properties in cardiac PCs via selective inhibition of I(NaL).

摘要

背景

既往研究表明,稳心颗粒(WXKL)是一种中药,通过多通道抑制作用发挥抗心律失常作用,但具体的药理作用仍有待阐明,特别是在心脏传导系统。

目的

探讨 WXKL 对心脏浦肯野纤维(PCs)的抗心律失常作用。

方法

采用全细胞膜片钳技术,从兔心中分离 PC,记录动作电位(AP)和离子电流。应用海兔毒素 II(ATX-II)和异丙肾上腺素(ISO)诱导早期后除极(EAD)、延迟后除极(DAD)或触发活动(TA)。

结果

WXKL(1 g/L 和 5 g/L)呈浓度和频率依赖性地缩短 PC 的动作电位时程(APD)。用 2 nM ATX-II 处理 PC 可延长 APD 并诱发 EAD,WXKL 可显著抑制 EAD。WXKL(1、5 g/L)还抑制 ISO 诱导的 EAD、DAD 和 TA。为了揭示离子机制,我们研究了 WXKL 对 PC 中的晚期钠电流(I(NaL))、峰值钠电流(I(NaP))和 L 型钙电流(ICaL)的影响。WXKL 可减弱 5 nM ATX-II 诱导的 I(NaL)增强,并以 4.3 ± 0.5 g/L 的 IC50 阻断 I(NaL),对 I(NaL)的选择性是 I(NaP)(13.3 ± 0.9 g/L)和 ICaL(17.6 ± 1.4 g/L)的 3-4 倍。此外,与氟卡尼相比,WXKL 对 I(NaP)的使用依赖性阻滞作用明显较小,表明其致心律失常作用较低。

结论

WXKL 通过选择性抑制 I(NaL)表现出抗心律失常作用。

相似文献

1
Antiarrhythmic effects and potential mechanism of WenXin KeLi in cardiac Purkinje cells.稳心颗粒对心肌浦肯野纤维的抗心律失常作用及机制研究。
Heart Rhythm. 2016 Apr;13(4):973-82. doi: 10.1016/j.hrthm.2015.12.023. Epub 2015 Dec 14.
2
Wenxin Keli diminishes Ca overload induced by hypoxia/reoxygenation in cardiomyocytes through inhibiting I and I.稳心颗粒通过抑制I和I减轻缺氧/复氧诱导的心肌细胞钙超载。
Pacing Clin Electrophysiol. 2017 Dec;40(12):1412-1425. doi: 10.1111/pace.13206. Epub 2017 Nov 16.
3
Antiarrhythmic effect of crotonoside by regulating sodium and calcium channels in rabbit ventricular myocytes.巴豆苷通过调节兔心室肌细胞钠钙通道的抗心律失常作用。
Life Sci. 2020 Mar 1;244:117333. doi: 10.1016/j.lfs.2020.117333. Epub 2020 Jan 18.
4
Naringin exerts antiarrhythmic effects by inhibiting channel currents in mouse cardiomyocytes.柚皮苷通过抑制心肌细胞通道电流发挥抗心律失常作用。
J Electrocardiol. 2023 Sep-Oct;80:69-80. doi: 10.1016/j.jelectrocard.2023.05.003. Epub 2023 May 13.
5
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.一种新型、强效、选择性的心脏晚期钠电流抑制剂可抑制实验性心律失常。
J Pharmacol Exp Ther. 2013 Jan;344(1):23-32. doi: 10.1124/jpet.112.198887. Epub 2012 Sep 25.
6
Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: Involvement of L‑type calcium and transient outward potassium currents.稳心颗粒减轻大鼠缺血性室性心律失常:涉及 L 型钙和瞬间外向钾电流。
Mol Med Rep. 2013 Feb;7(2):519-24. doi: 10.3892/mmr.2012.1195. Epub 2012 Nov 21.
7
Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels.芭尔巴因通过调节电压门控离子通道抑制兔心室性心律失常。
Acta Pharmacol Sin. 2018 Mar;39(3):357-370. doi: 10.1038/aps.2017.93. Epub 2017 Oct 26.
8
Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli.稳心颗粒抗心律失常中药的靶基因鉴定。
Cardiovasc Ther. 2020 May 27;2020:3480276. doi: 10.1155/2020/3480276. eCollection 2020.
9
Icariin, a Novel Blocker of Sodium and Calcium Channels, Eliminates Early and Delayed Afterdepolarizations, As Well As Triggered Activity, in Rabbit Cardiomyocytes.淫羊藿苷,一种新型钠通道和钙通道阻滞剂,可消除兔心肌细胞中的早期和延迟后去极化以及触发活动。
Front Physiol. 2017 May 29;8:342. doi: 10.3389/fphys.2017.00342. eCollection 2017.
10
Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current.稳心颗粒通过选择性抑制晚钠电流抑制心室触发型心律失常。
Pacing Clin Electrophysiol. 2013 Jun;36(6):732-40. doi: 10.1111/pace.12109. Epub 2013 Feb 25.

引用本文的文献

1
Identification of Lauric Acid as a Potent Sodium Channel Na1.5 Blocker from Compound Chinese Medicine Wenxin Keli.从复方中药稳心颗粒中鉴定出月桂酸作为一种有效的钠通道Na1.5阻滞剂。
Drug Des Devel Ther. 2025 Jan 9;19:141-157. doi: 10.2147/DDDT.S485723. eCollection 2025.
2
The Therapeutic Potential of Four Main Compounds of (Roxb.) DC: A Comprehensive Study on Biological Processes, Anti-Inflammatory Effects, and Myocardial Toxicity.(罗克斯伯)DC四种主要化合物的治疗潜力:关于生物过程、抗炎作用和心肌毒性的综合研究
Pharmaceuticals (Basel). 2024 Apr 19;17(4):524. doi: 10.3390/ph17040524.
3
Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signaling.
锌指蛋白转录因子16通过硫氧还蛋白相互作用蛋白-硫氧还蛋白2信号通路增加2型糖尿病小鼠心房颤动的易感性。
Cell Mol Life Sci. 2024 Feb 13;81(1):88. doi: 10.1007/s00018-024-05125-2.
4
Efficacy and safety of Wenxin Keli combined with metoprolol tartrate in the treatment of premature ventricular contractions: A systematic review and meta-analysis.稳心颗粒联合酒石酸美托洛尔治疗室性早搏的疗效与安全性:一项系统评价与Meta分析
Front Cardiovasc Med. 2022 Jul 29;9:952657. doi: 10.3389/fcvm.2022.952657. eCollection 2022.
5
Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach.基于网络药理学方法探讨稳心颗粒治疗心房颤动的分子靶点及作用通路
Evid Based Complement Alternat Med. 2020 Oct 7;2020:8396484. doi: 10.1155/2020/8396484. eCollection 2020.
6
Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli.稳心颗粒抗心律失常中药的靶基因鉴定。
Cardiovasc Ther. 2020 May 27;2020:3480276. doi: 10.1155/2020/3480276. eCollection 2020.
7
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation.稳心颗粒联合胺碘酮与胺碘酮单药治疗近期发作心房颤动的疗效比较
Cardiol Res Pract. 2018 Dec 4;2018:6047271. doi: 10.1155/2018/6047271. eCollection 2018.
8
Disease Modifiers of Inherited Channelopathy.遗传性通道病的疾病修饰因子
Front Cardiovasc Med. 2018 Oct 1;5:137. doi: 10.3389/fcvm.2018.00137. eCollection 2018.
9
Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview.稳心颗粒对心血管疾病的治疗作用:实验与机制综述
Front Pharmacol. 2018 Sep 5;9:1005. doi: 10.3389/fphar.2018.01005. eCollection 2018.
10
The transient receptor potential melastatin 4 channel inhibitor 9-phenanthrol modulates cardiac sodium channel.瞬时受体电位 melastatin 4 通道抑制剂 9-菲咯啉调节心脏钠离子通道。
Br J Pharmacol. 2018 Dec;175(23):4325-4337. doi: 10.1111/bph.14490. Epub 2018 Oct 14.